This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Maria Fritsch-Fredin: Innovator in Metabolic Disease Treatments
Introduction
Maria Fritsch-Fredin is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of metabolic disease treatments, particularly focusing on obesity. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Among her latest patents, Maria has developed glucagon/GLP-1 agonists for the treatment of obesity. This disclosure provides GLP-1/glucagon agonist peptides aimed at addressing metabolic diseases, such as obesity. Her research is crucial in the ongoing battle against obesity and its related health issues.
Career Highlights
Maria is currently employed at MedImmune Limited, where she continues to advance her research and development efforts. Her work at this esteemed company has allowed her to focus on groundbreaking innovations in the treatment of metabolic disorders.
Collaborations
Maria has collaborated with notable colleagues, including Balaji Agoram and Madeleine Antonsson. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Maria Fritsch-Fredin is a dedicated inventor whose work in metabolic disease treatments is making a significant impact. Her innovative approaches and collaborations are essential in the fight against obesity and related health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile